Journey Medical Corp (DERM) — Capital Reinvestment Ratio
Latest as of March 2022:
22.62x
Journey Medical Corp (DERM) has a Capital Reinvestment Ratio of 22.62x as of March 2022, meaning it reinvests 23% of its operating cash flow ($884.00K) in capital expenditures ($20.00 Million). See how much free cash does Journey Medical Corp generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
22.62x
Capex / Operating Cash Flow
Operating Cash Flow
$884.00K
USD
Capital Expenditures
$20.00 Million
USD
Data as of
Mar 2022
Most recent filing
Journey Medical Corp Capital Reinvestment Ratio (2019–2023)
This chart tracks Journey Medical Corp's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Journey Medical Corp (2019–2023)
Year-by-year Capital Reinvestment Ratio for Journey Medical Corp from 2019 to 2023. For live market cap and broader valuation context, see Journey Medical Corp stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.95x | $5.24 Million | $5.00 Million | ▲ +308.1% |
| 2020 | 0.23x | $5.13 Million | $1.20 Million | ▼ -12.1% |
| 2019 | 0.27x | $9.02 Million | $2.40 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow